Spotlight On ATTR-CM

Episodes 1-16 of 20

Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Heart Matters
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Heart Matters
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
- Ryan Quigley
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Heart Matters
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
- Kevin Alexander, MD
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Heart Matters
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
- Kevin Alexander, MD
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Heart Matters
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Heart Matters
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Heart Matters
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Heart Matters
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
- Ahmad Masri, MD, MS
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Heart Matters
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
- Ahmad Masri, MD, MS
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Heart Matters
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Heart Matters
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD
Treating ATTR-CM: Current Strategies and Emerging Options
Treating ATTR-CM: Current Strategies and Emerging Options
Heart Matters
Treating ATTR-CM: Current Strategies and Emerging Options
- Frederick Ruberg, MD
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Heart Matters
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
- Michelle Kittleson, MD, PhD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Heart Matters
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
- Michelle Kittleson, MD, PhD
Understanding the Pathophysiology Behind ATTR-CM
Understanding the Pathophysiology Behind ATTR-CM
Heart Matters
Understanding the Pathophysiology Behind ATTR-CM
- Frederick Ruberg, MD

1/2

Episodes 1-16 of 20

Title

Share on ReachMD

Welcome to Global Cardiology Academy

Welcome to Global
Cardiology Academy